Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Preliminary phase III results of Civacir to prevent HCV reinfection in liver transplant patients

May 6, 2015

Ebola vaccine based on the 2014 Zaire Guinea epidemic strain: Phase I clinical data

May 6, 2015

Tamir Biotechnology updates development progress of TMR-004 for Ebola

May 5, 2015

Discovery of a bacterial RNR-targeting antibiotic to combat resistance

May 5, 2015

Arno's AR-12 receives E.U. orphan drug status for cryptococcosis and tularemia

May 4, 2015

Pharmacokinetic assessments of RG-101 in healthy volunteers and HCV patients

May 4, 2015

Phase I trial confirms anti-HCV activity of SB-9200

April 30, 2015

Potent in vitro activity of AP-138, a second-generation plectasin derivative

April 30, 2015

Clinical development of the nucleoside NS5B inhibitor MIV-802 for HCV infection

April 29, 2015

Phase III data for CAZ-104 presented at ECCMID

April 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...